RBC Capital Markets Reiterates Drax Group (DRXGF) Outperform Recommendation

RBC Capital Markets reiterated an Outperform rating for Drax Group (DRXGF), projecting an average one-year price target of $11.05/share, which suggests an 81.37% upside from its recent closing price of $6.09. The company is forecast to achieve $8,029MM in annual revenue, representing a 42.08% increase, and a non-GAAP EPS of $1.35. Institutional sentiment shows a slight decrease in the number of funds holding positions, but an increase in average portfolio weight by 10.10%, despite a 9.47% reduction in total institutional shares owned.

Analysis

RBC Capital Markets has reiterated an "Outperform" rating for Drax Group (DRXGF) as of November 5, 2025, setting an average one-year price target of $11.05/share. This target implies a substantial 81.37% upside from the recent closing price of $6.09, signaling strong analyst conviction in the company's future performance. The forecasts range from a low of $9.42 to a high of $14.22.

The positive outlook is underpinned by robust financial projections, with Drax Group anticipated to report annual revenue of $8,029 million, marking a significant 42.08% year-over-year increase. Furthermore, the company is projected to achieve a non-GAAP EPS of $1.35, reinforcing expectations for strong fundamental growth.

Institutional investor sentiment presents a mixed but generally positive signal. While the number of funds holding DRXGF decreased by 2.34% (3 owners) and total institutional shares owned declined by 9.47% in the last quarter, the average portfolio weight dedicated to DRXGF across reporting funds increased by 10.10%. This suggests that existing institutional holders are increasing their proportional allocation to the stock, despite a slight reduction in overall institutional presence.

Specific fund actions highlight this dynamic; Avantis International Small Cap Value ETF (AVDV) notably increased its share count by 9.11% and portfolio allocation by 1.42%. Similarly, despite a minor reduction in shares, Vanguard Total International Stock Index Fund (VGTSX) also increased its portfolio allocation by 2.42%, indicating a targeted increase in conviction among some large investors.

Key Decisions for Investors

• Evaluate DRXGF's potential for capital appreciation given RBC Capital Markets' "Outperform" rating and the implied 81.37% price target upside to $11.05.
• Analyze the nuanced institutional ownership data, noting the increase in average portfolio weight (+10.10%) despite a 9.47% decrease in total shares, to understand conviction levels among existing holders.
• Monitor the company's execution against its projected 42.08% revenue growth and $1.35 non-GAAP EPS, as these are critical drivers for validating the optimistic analyst outlook.